JM
Therapeutic Areas
BioStem Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VENDAJE® | Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers) | Commercial |
| VENDAJE AC® | Chronic Wounds (Antimicrobial application) | Commercial |
| VENDAJE® Optic | Ophthalmologic Applications (Pterygium, Corneal Repair) | Commercial |
| AmnioWrap2™ | Wound Care, Surgical Repair | Commercial |
Leadership Team at BioStem Technologies
AV
Andrew Van Vurst
Chief Operating Officer
BP
Brandon Poe
Chief Financial Officer
BH
Barry Hassett
Chief Commercial Officer
DW
Dr. Wendy W. Weston
Vice President of R&D
NA
Noah Agron
Vice President of Corporate Finance and Strategy
MF
Michael Fortunato
Chief Accounting Officer
JH
Jeff Humke
Vice President of Human Resources
TD
Thomas Dugan
Board Member
JU
Jodi Ungrodt
Board Member
KW
Kenneth Warrington, Ph.D.
Board Member, Scientific Advisory Board